Ebola Vaccine: How Far are we?

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 5

Abstract

Ebola viruses have been identified as an emerging threat as it causes severe haemorrhagic fever in human with mortality rates ranging from 50 to 90%. In addition to being a global health concern, the virus also is considered a potential biological threat agent. As for now, no licensed vaccine is available for pre or post exposure treatment. Recent epidemic of this disease in South Africa has led to concern towards development of an effective vaccine on a priority basis. This review is an attempt to look upon current progress in the development of Ebola virus vaccines and highlights strategies that have the greatest potential for commercial development.

Authors and Affiliations

Rajani Sharma, Ketki Jangid, Dr. Anuradha

Keywords

Related Articles

Socket Preservation using Platelet Rich Fibrin for Pink Aesthetics- A Case Report

ABSTRACT Post extraction preservation of interdental papillae, poses a challenge to the clinicians exclusively when related to the restoration of missing anterior teeth. In the modern era, patients claim for aesthetics,...

Cholesterol Management in Indians: Should We Treat the Targets or Treat the Risk?

Abstract Clinical evidence on relationship between cholesterol and Cardiovascular Disease (CVD) has highlighted the importance of all lipid components in the pathogenesis of CVD, thereby generating the concepts of “targe...

Glycaemic Control and Inflammatory Mediators in Diabetic Patients with Coronary Artery Disease

ABSTRACT Introduction: Glycaemic control in diabetic patients is directly related to the severity of Coronary Artery Disease (CAD) and increased morbidity and mortality rates. Inflammation plays an important role in the...

Prevalence of Childhood Hypertension in South Asia: A Systematic Review and Meta-Analysis

ABSTRACT Introduction: Hypertension is an emerging problem among children and adolescents in both developing and developed countries. Early diagnosis of hypertension is important to reduce the morbidity associated with...

Spontaneous Enterocutaneous Fistula Resulting from Richter’s Hernia

Richter’s hernia is due to the entrapment of a part of circumference of the bowel wall. As the bowel continuity is maintained, the patients usually do not have intestinal obstruction. Some patients with Richter’s hernia...

Download PDF file
  • EP ID EP341305
  • DOI 10.7860/JCDR/2017/22184.9863
  • Views 65
  • Downloads 0

How To Cite

Rajani Sharma, Ketki Jangid, Dr. Anuradha (2017). Ebola Vaccine: How Far are we?. Journal of Clinical and Diagnostic Research, 11(5), 1-4. https://europub.co.uk/articles/-A-341305